Iambic Therapeutics · 2 months ago
Sr Associate Scientist I or II, GPCR Biology
Iambic Therapeutics is a clinical-stage life-science and technology company focused on developing novel medicines through an AI-driven discovery platform. They are seeking a Senior Associate Scientist I/II to support in vitro cell-based assays and advance pre-clinical projects in the GPCR Biology group, collaborating with cross-functional teams to enhance small-molecule therapeutics design and discovery.
Artificial Intelligence (AI)Machine LearningSoftwareTherapeutics
Responsibilities
Work closely with the Biology group to independently conceptualize, design and conduct in vitro studies aimed at supporting hit to lead medicinal chemistry efforts targeting GPCRs
Independently manage CRO scientists in the design, development, and implementation of in vitro assays for the advancement of GPCR projects
Execute weekly cell-based assays to screen/evaluate small molecule compounds in coordination with Biology, Chemistry, and Compound Management groups
Interpret and analyze scientific data and work with cross functional teams to QC/communicate data in a timely manner
Present experimental results/updates at team meetings
Contribute to the management of the biology laboratory
Qualification
Required
Bachelor's or master's degree in biochemistry, pharmacology, cell biology, or other related scientific areas with a minimum of 3-5 years of industry experience
Demonstrated scientific rigor with proven ability to critically evaluate data, and think independently and creatively in developing and testing new scientific hypotheses
Hands-on experience in cell biology and routine biological assays, including cell culture, HTRF and reporter gene cell-signaling assays, and imaging assays
Excellent oral and written communication skills is required
Highly motivated to work in a cross-functional team setting
Flexibility and ability to quickly learn new skills and knowledge on the job
Preferred
Hands-on experience with traditional and innovative screening methodologies for GPCRs, as well as concepts related to GPCR signaling and trafficking highly preferred
Familiarity with HTS screening methodology is highly desirable
Experience with design and implementation of in vivo models in coordination with CROs is highly desirable
Benefits
Company paid healthcare
Flexible spending accounts
Voluntary life insurance
401K matching
Uncapped vacation
Company
Iambic Therapeutics
Iambic is a clinical-stage life-science and technology company developing novel medicines using its AI-driven discovery and development platform.
Funding
Current Stage
Growth StageTotal Funding
$303M2025-11-10Series Unknown· $100M
2024-04-24Series B· $50M
2023-10-03Series B· $100M
Recent News
2025-12-16
2025-11-30
Company data provided by crunchbase